Fineotex Chemical Board Approves Stock Split, Bonus Issue

Fineotex Chemical Ltd has received shareholder approval for a stock split and bonus issue during its extraordinary general meeting (EGM) held on October 25, 2025. As per the exchange filings, the company has fixed October 31, 2025, as the record date to determine shareholders eligible for both actions.

Stock Split Details

The company will subdivide each equity share of face value ₹2 into two equity shares of ₹1 each, fully paid up. The decision was first proposed in September and confirmed in October 2025 before being approved at the EGM. This is aimed at increasing the number of shares in circulation and making them more accessible to investors.

Bonus Issue Ratio

Following the stock split, Fineotex Chemical will issue 4 fully paid-up bonus shares of ₹1 each for every 1 share held. The deemed date of allotment for the bonus shares has been fixed as November 3, 2025, in accordance with the SEBI circular issued on September 16, 2024. This will be the company’s second bonus issue; the first was announced in 2015 in a 1:1 ratio, as per BSE records.

Shareholder Approval

According to the company’s filing, 99.99% of votes cast were in favour of both resolutions, the share split and the bonus issue. The company informed the exchanges that these actions had been under consideration since September 27, 2025 and were approved after receiving the required shareholder consent.

Company Background

Fineotex Chemical manufactures specialty chemicals used in the textile, home care, and hygiene industries. The company has expanded its product range and operations in recent years.

Fineotex Chemical Share Price Performance 

As of October 28, 2025, 09:28 AM, Fineotex Chemical share price was trading at ₹254, a 0.003% decline from the previous closing price. 

Read More: Adani Enterprises Incorporates Shri Kedarnath Ropeways Limited for Uttarakhand Ropeway Project!

Conclusion

Fineotex Chemical will now move forward with the implementation of the stock split and bonus issue. The record date and allotment timeline are set, and the process will be completed in line with regulatory requirements.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.